These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15162916)

  • 21. Bioequivalence of two oral ciprofloxacin tablets formulations.
    Cuadrado A; Gascón AR; Solinís MA; Ramírez E; Hernández RM; Knie U; Pedraz JL
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):336-41. PubMed ID: 15222727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative bioavailability of two oral formulations of levofloxacin in healthy Mexican volunteers.
    M ; Flores-Murrieta FJ
    Int J Clin Pharmacol Ther; 2009 Apr; 47(4):283-6. PubMed ID: 19356395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
    Bonn M; Eydeler U; Barkworth M; Rovati LC
    Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of bioequivalence of a generic mefloquine tablet with the standard product.
    Weidekamm E; Rüsing G; Caplain H; Sörgel F; Crevoisier C
    Eur J Clin Pharmacol; 1998 Oct; 54(8):615-9. PubMed ID: 9860148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetic and bioequivalence study of azithromycin 500 mg tablet in healthy Bangladeshi volunteers.
    Ahmed MU; Islam MS; Shohag H; Karim R; Mostofa AG; Bhuiyan NH; Rahim M; Hasnat A
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):452-8. PubMed ID: 22677307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
    Nakade S; Komaba J; Ohno T; Kitagawa J; Furukawa K; Miyata Y
    Int J Clin Pharmacol Ther; 2008 Jan; 46(1):42-7. PubMed ID: 18218297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic study and comparative bioavailability of two nelfinavir tablet formulations in Iranian healthy volunteers after a low-dose administration.
    Derakhshandeh K; Sohrabi A
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):491-8. PubMed ID: 19640357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions.
    Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A
    Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin: use pattern in Estonia and bioavailability of the local market leader.
    Pähkla R; Irs A; Oselin K; Rootslane L
    J Clin Pharm Ther; 1999 Oct; 24(5):375-80. PubMed ID: 10583701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of fasting bioavailability among 100-mg commercial, 100-mg generic, and 50-mg chewable generic sildenafil tablets in healthy male Mexican volunteers: a single-dose, 3-period, crossover study.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; García-González A; Ramírez-San Juan E
    Clin Ther; 2012 Mar; 34(3):689-98. PubMed ID: 22386826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad® versus Zinnat®) in healthy male volunteers.
    Asiri YA; Al-Hadiya BM; Kadi AA; Al-Khamis KI; Mowafy HA; El-Sayed YM
    Int J Clin Pharmacol Ther; 2011 Sep; 49(9):571-6. PubMed ID: 21888870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers.
    Kanjanawart S; Gaysonsiri D; Phunikom K; Simasathiansopon S; Tangsucharit P; Vannaprasaht S; Kaewkamson T; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):249-54. PubMed ID: 23357835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence of two lamivudine tablet formulations.
    Santos-Magalhães NS; Pontes A; Cavalcante RM; Costa RM; Rangel FA; Guimarães MI; de Carvalho JN; de Souza SD; de Oliveira HM; Esteves IL; Ramalho MS; Vieira SL; Alves AJ
    Arzneimittelforschung; 2001; 51(4):310-4. PubMed ID: 11367872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Mar; 63(3):150-8. PubMed ID: 23444169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.